- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05182372
Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities (COACH)
Study Overview
Detailed Description
Insomnia is a debilitating condition that impacts one third of adults, with a majority not having access to proper treatment. Digital Cognitive Behavioral Treatment for Insomnia (dCBT-I). is a method that is becoming more accessible and with strong success rate with treatment completion; however, non-completion rates are common, specifically in those with low socioeconomic status (SES).
This study will examine the addition of telehealth coaching to dCBT-I to increase adherence rates. Telehealth coaching will aim to provide support to mitigate the impact of lower health literacy, and will also enhance self-efficacy as a mechanism to promote treatment persistence.
Participants will be recruited from the Henry Ford Health System (HFHS) outpatient network as well as the Medicare/Medicaid data warehouse. Subjects will be screened to determine eligibility, and then will be randomized into one of two insomnia treatment groups (control dCBT-I and dCBT-I with telehealth coaching). Treatment involves 6 weekly dCBT-I sessions. In the dCBT-I with coaching component, those who are at risk for treatment non-completion will be offered two telehealth sessions of brief behavioral therapy for insomnia. Those in the control dCBT-I who are at risk for treatment non-completion will be provided digital sleep education.
At the end of the treatment period, some participants will complete a semi-structured interview to assess for facilitators and barriers to treatment engagement.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alec Bayoneto, BS
- Phone Number: 2483444159
- Email: abayone1@hfhs.org
Study Contact Backup
- Name: Philip Cheng, PhD
- Phone Number: (248)344-7361
- Email: pcheng1@hfhs.org
Study Locations
-
-
Michigan
-
Novi, Michigan, United States, 48377
- Recruiting
- Henry Ford Columbus Medical Center
-
Contact:
- Philip Cheng, PhD
- Phone Number: 2493447361
- Email: pcheng1@hfhs.org
-
Principal Investigator:
- Philip Cheng, PhD
-
Contact:
- Alec Bayoneto, B.S.
- Phone Number: 248-344-4159
- Email: abayone1@hfhs.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Determination of insomnia (ISI >14)
Exclusion Criteria:
- Age < 18
- Unwillingness/inability to participate
- Bipolar or Seizure Disorders
- Untreated sleep disorders other than insomnia
- Untreated and severe medical or psychiatric disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Enhanced dCBT-I
This group will complete d-CBTI and be assigned a coach that will help with completion of the treatment and will be available to call personally to discuss questions and issues.
|
Telehealth Coaching
|
No Intervention: Control dCBT-I
Participants in this group will complete dCBT-I individually without assistance from a healthcare provider
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk of treatment non-completion
Time Frame: throughout the study until the final study visit, up to 6 weeks
|
Determined based on missing two consecutive sessions of dCBT-I.Missing two consecutive sessions equals being behind on sessions by 14 days.
|
throughout the study until the final study visit, up to 6 weeks
|
Treatment Completion
Time Frame: throughout the study until the final study visit, up to 6 weeks
|
Completion of all 6 sessions of dCBT-I.
|
throughout the study until the final study visit, up to 6 weeks
|
Adherence to Sleep Restriction
Time Frame: throughout the study until the final study visit, up to 6 weeks
|
Determined based on the variance of sleep diary variables
|
throughout the study until the final study visit, up to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia
Time Frame: throughout the study until the final study visit, up to 6 weeks
|
Insomnia Severity Index Score (0 to 28; higher scores correspond to worse severity)
|
throughout the study until the final study visit, up to 6 weeks
|
Physical Environment
Time Frame: within 2 weeks of post-treatment
|
Participants will be asked about the layout of their sleep environment as well as neighborhood characteristics.
Sleep environment will be assessed using qualitative information on individual's surroundings and information such as their ability to adjust light levels, temperature, and sound.
If it is easier for the individual to adjust these, then they have a better physical environment for sleep.
Neighborhood characteristics will be evaluated with the Neighborhood Safety scale (scores range from 1 to 5; lower scores indicate more neighborhood safety).
|
within 2 weeks of post-treatment
|
Sociocultural environment
Time Frame: within 2 weeks of post-treatment
|
Sociocultural environment is measured using a household roster and the Everyday Discrimination Scale.
A household roster will ask participants to report the number of individuals in the household and characterize the relationship with the participant.
No summary score exists for the household roster.
The Everyday Discrimination Scale measures frequency of discrimination (scores range from 10 to 60; higher scores represent more frequent experiences of discrimination).
|
within 2 weeks of post-treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Philip A Cheng, PhD, Henry Ford Health System
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14816
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
Clinical Trials on Enhanced dCBT-I
-
Chinese University of Hong KongNot yet recruitingAdolescent | Depression | InsomniaHong Kong
-
Women's Hospital School Of Medicine Zhejiang UniversityNot yet recruitingDigital Cognitive Behavioral Therapy for Insomnia (dCBT-I)
-
McGill UniversitySleepioTerminatedInsomnia Disorder | HIV - Human Immunodeficiency VirusCanada
-
Norwegian University of Science and TechnologyRecruitingInsomnia | Pain, ChronicNorway
-
Peking University First HospitalZeen health (Beijing) Technology Co., LtdCompleted
-
St. Olavs HospitalUniversity of California, Berkeley; Norwegian University of Science and Technology and other collaboratorsActive, not recruiting
-
Massachusetts General HospitalNot yet recruitingInsomnia | Postoperative Delirium | Delayed Neurocognitive Recovery | Postoperative Neurocognitive DisorderUnited States
-
University College DublinIrish Cancer Society; Big Health Ltd.; Research Electronic Data Capture (REDCap)Not yet recruiting
-
University of California, IrvineNational Institute of Mental Health (NIMH); University of California, Berkeley and other collaboratorsRecruitingDepression, AnxietyUnited States
-
MICHAEL A GRANDNERUniversity of PennsylvaniaEnrolling by invitationSleep Initiation and Maintenance Disorders | Suicidal IdeationUnited States